Hormone-sensitive lipase activity and triacylglycerol hydrolysis are decreased in rat soleus muscle by cyclopiazonic acidWATT, Matthew J; STEINBERG, Gregory R; HEIGENHAUSER, G. J. F et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 2, pp E412-E419, issn 0193-1849Article

Small molecule inhibitors of BRAF in clinical trialsZAMBON, Alfonso; NICULESCU-DUVAZ, Ion; NICULESCU-DUVAZ, Dan et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 789-792, issn 0960-894X, 4 p.Article

Indole RSK inhibitors. Part 2: Optimization of cell potency and kinase selectivityKIRRANE, Thomas M; BOYER, Stephen J; KUGLER, Stanley et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 738-742, issn 0960-894X, 5 p.Article

Involvement of spinal tyrosine kinase in inflammatory and N-methyl-D-aspartate-induced hyperalgesia in ratsSATO, Eiru; TAKANO, Yoshito; KUNO, Yuichiro et al.European journal of pharmacology. 2003, Vol 468, Num 3, pp 191-198, issn 0014-2999, 8 p.Article

Protein kinase Cα and ε small-molecule targeted therapeutics : a new roadmap to two Holy Grails in drug discovery?O'BRIAN, Catherine A; FENG CHU; BORNMANN, William G et al.Expert review of anticancer therapy. 2006, Vol 6, Num 2, pp 175-186, issn 1473-7140, 12 p.Article

Third-Generation Tyrosine Kinase Inhibitors and BeyondQUINTAS-CARDAMA, Alfonso; KANTARJIAN, Hagop; CORTES, Jorge et al.Seminars in hematology. 2010, Vol 47, Num 4, pp 371-380, issn 0037-1963, 10 p.Article

The function of cyclin-dependent kinase inhibitor p21^{Cip-1/SDI-1-WAF-1} in chondrogenic differentiationNEGISHI, Yoichi; KAWASHIMA, Kohtaro.Recent research developments in biophysics and biochemistry vol. 4 - 2004 Part I. Recent research developments in biophysics and biochemistry. 2004, pp 175-187, isbn 81-7736-214-3, 13 p.Book Chapter

Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic StrategiesLOVLY, Christine M; SHAW, Alice T.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2249-2256, issn 1078-0432, 8 p.Article

Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorBLAY, Jean-Yves; VON MEHREN, Margaret.Seminars in oncology. 2011, Vol 38, Num 2, issn 0093-7754, S3-S9, SUP1Article

NilotinibDEININGER, Michael W.Clinical cancer research. 2008, Vol 14, Num 13, pp 4027-4031, issn 1078-0432, 5 p.Article

The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107VON BUBNOFF, N; GORANTLA, S. H. P; KANCHA, R. K et al.Leukemia. 2005, Vol 19, Num 9, pp 1670-1671, issn 0887-6924, 2 p.Article

Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumorsMURAKAMI, Haruyasu; UEDA, Yutaka; SHIMOYAMA, Tatsu et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 5, pp 1119-1128, issn 0344-5704, 10 p.Article

Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agentYANTING ZHANG; YAQIONG ZHANG; SHENGRONG GUO et al.International journal of pharmaceutics (Print). 2009, Vol 369, Num 1-2, pp 19-23, issn 0378-5173, 5 p.Article

Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitorROUTHOUSKA, Shannon; GILLIAM, Anita C; MIRMIRANI, Paradi et al.Archives of dermatology (1960). 2006, Vol 142, Num 11, pp 1477-1479, issn 0003-987X, 3 p.Article

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemiaRONG CHEN; WIERDA, William G; CHUBB, Sherri et al.Blood. 2009, Vol 113, Num 19, pp 4637-4645, issn 0006-4971, 9 p.Article

Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21^CIP1/WAF1 by iron depletion. CommentaryHERSHKO, Chaim; DONG FU; RICHARDSON, Des R et al.Blood. 2007, Vol 110, Num 2, issn 0006-4971, 474-475, 752-761 [12 p.]Article

Systemic therapy in neurofibromatosis type 2LIM, Stephanie Hui-Su; ARDERN-HOLMES, Simone; MCCOWAGE, Geoffrey et al.Cancer treatment reviews. 2014, Vol 40, Num 7, pp 857-861, issn 0305-7372, 5 p.Article

Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosisCAPONETTI, Gabriel C; MIRANDA, Roberto N; ALTHOF, Pamela A et al.Human pathology. 2012, Vol 43, Num 12, pp 2223-2228, issn 0046-8177, 6 p.Article

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemiaMILOJKOVIC, Dragana; NICHOLSON, Emma; KHORASHAD, Jamshid S et al.Haematologica (Roma). 2010, Vol 95, Num 2, pp 224-231, issn 0390-6078, 8 p.Article

Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia : when to change? A perspective in 2009MAURO, Michael J.Current opinion in hematology. 2009, Vol 16, Num 2, pp 135-139, issn 1065-6251, 5 p.Article

Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesionsEL-GHOBASHY, Alaa A; SHAABAN, Abeer M; INNES, Jenny et al.European journal of cancer (1990). 2007, Vol 43, Num 13, pp 1211-1218, issn 0959-8049, 8 p.Article

Diagnosis and treatment of hypereosinophilic syndromesFLETCHER, Sarah; BAIN, Barbara.Current opinion in hematology. 2007, Vol 14, Num 1, pp 37-42, issn 1065-6251, 6 p.Article

A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesisKANKANALA, J; LATHAM, A. M; JOHNSON, A. P et al.British journal of pharmacology. 2012, Vol 166, Num 2, pp 737-748, issn 0007-1188, 12 p.Article

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapyPEMMARAJU, Naveen; KANTARJIAN, Hagop; SHAN, Jianqin et al.Haematologica (Roma). 2012, Vol 97, Num 7, pp 1029-1035, issn 0390-6078, 7 p.Article

MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaksMEDOVA, Michaela; AEBERSOLD, Daniel M; ZIMMER, Yitzhak et al.International journal of cancer (Print). 2012, Vol 130, Num 3, pp 728-734, issn 0020-7136, 7 p.Article